Study Finds New Eye Drops to Improve Night Vision
Eye drops developed by Opus Genetics have significantly improved night vision in individuals who struggle to drive in the dark, according to results from two late-stage studies.
Eye drops developed by Opus Genetics have significantly improved night vision in individuals who struggle to drive in the dark, according to results from two late-stage studies.
Article outline
- What happened
- The key numbers
- Why it matters
- The details
- The bottom line
Key points
- Add ProPakistani to Preferred Sources and see more of our stories in Google Search and Top Stories.
- Participants received either 0.75% phentolamine ophthalmic solution or a placebo for eight or 15 days.
- While the placebo group remained at 3%, by day 15, the improvement rate rose to 21% in the treatment group.
- The US Food and Drug Administration has granted Fast Track designation to the eye drops for treating chronic night driving impairment.
- Add as a preferredSource on Google Follow on Google News Join WhatsApp.
In the first trial, researchers enrolled 145 patients with poor vision in dim or dark settings along with symptoms such as glare, halos, and starbursts.
Participants received either 0.75% phentolamine ophthalmic solution or a placebo for eight or 15 days. Premature Babies in Pakistan Face Risk of Blindness.
After eight days, 13% of patients given the eye drops improved by at least three lines on eye charts, compared with 3% in the placebo group.
Patients additionally noted less trouble with glare, halos and starbursts. By day 15, those using the eye drops indicated a statistically significant improvement in overall night vision difficulties.
Researchers remarked the drops work by acting on a muscle in the iris and causing moderate pupil constriction that can last for at least 20 hours.
Plenty of of the participants had developed these vision matters after procedures such as LASIK surgery. Punjab Suspends Glycosting Injection Supply.
Opus Genetics additionally noted encouraging early results from a second Phase III trial. The firm stated patients experienced a better ability to see the road under oncoming headlights and improved vision in dawn or dusk glare.
For context, the US Food and Drug Administration has granted Fast Track designation to the eye drops for treating chronic night driving impairment. It could speed up the approval process. Stay Connected with ProPakistani.
Obtain the latest news, tech updates, telecom insights, and business stories wherever you prefer. Follow on Google Discover.
Taken together, the developments around study Finds New Eye Drops to Improve Night Vision point to a situation that is still moving, and the coming days should bring more clarity.


